Zelboraf 240mg
- Medicine Name: Zelboraf
- API: Vemurafenib
- Dosage Form & Strength: Tablets: 240 mg
- Manufactured By: Roche and Plexxikon
Medical Uses
Zelboraf (vemurafenib) is an oral, small-molecule kinase inhibitor used for the treatment of patients with BRAF V600 mutation-positive advanced or inoperable melanoma and Erdheim-Chester Disease with BRAF V600 mutation. It is designed to block some mutated forms of BRAF, which cause abnormal signaling inside unhealthy cells that cause tumor growth.
Recommended Dosage: The recommended dose of Vemurafenib is 960 mg (four 240 mg tablets) orally every 12 hours with or without a meal. A missed/skipped dose can be taken up to 4 hours before the very next scheduled dose. Treat patients with Vemurafenib until there is evidence of disease progression or unacceptable toxicity. Do not take an additional dose of Vemurafenib if vomiting occurs after taking the dose, but continue with the next scheduled dose. It is not advisable to crush or chew the tablets.
Warning & Precautions
- Treatment with Vemurafenib can increase the chance of developing new primary cancers, such as squamous cell carcinoma and melanoma. Monitor patients regularly and treat them as needed. Let your doctor know about any unusual skin changes or growths.
- Serious allergic reactions, including rash, fever, or organ swelling, may occur. Stop using this drug immediately and contact your healthcare professional in case signs of hypersensitivity, such as difficulty breathing or severe rash, develop.
- Vemurafenib 240 mg may cause serious skin reactions, including Stevens-Johnson syndrome. Monitor for rashes, blistering, or peeling skin. Contact your doctor immediately if severe skin issues occur during treatment.
- Vemurafenib oral tablets can affect heart rhythm, causing QT prolongation, which may lead to irregular heartbeat. Regular heart monitoring is essential. Inform your doctor if you experience dizziness, fainting, or a rapid heartbeat.
- Eye problems, including uveitis and retinal vein occlusion, can occur. Let your doctor know if you experience vision changes, eye pain, or redness. Regular eye exams are recommended during treatment.
- Vemurafenib can harm an unborn baby. Do not use this therapy during pregnancy. Women of childbearing age should use effective contraception during treatment and for at least 2 weeks after the last dose.
- Do not breastfeed while using this oral therapy and for 2 weeks after stopping it. It is not known if Vemurafenib passes into breast milk, but it could harm the baby. Always consult your doctor before breastfeeding.
Documentation & Availability
What documents are required to import ZELBORAF to India?
ZELBORAF (vemurafenib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is ZELBORAF available in India?
ZELBORAF (vemurafenib tablet) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is the facilitator providing input
- On availability of Zelboraf in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
ZELBORAF can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of ZELBORAF (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Zelboraf tablets 240 mg price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare can source ZELBORAF (Cancer Treatment Medicines) from across the globe and can supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Zelboraf®?
Vemurafenib is a Generic Name for the trade name drug Zelboraf®.
What is the Manufacturer’s Name of Zelboraf®?
Zelboraf® is manufactured by Roche and Plexxikon.
Is Zelboraf® approved by the FDA?
Yes, Zelboraf® is approved by the FDA. Date of first approval: August 17, 2011.
What is the dosage and form of Zelboraf® supplied?
Zelboraf is supplied in Tablet: 240 mg for oral administration.
What are the most common side effects of Zelboraf®?
The most common side effects of Zelboraf® are
- Melanoma: arthralgia, nausea, rash, fatigue, photosensitivity reaction, alopecia, pruritus, and skin papilloma.
- Erdheim-Chester Disease: arthralgia, fatigue, rash maculopapular, alopecia, electrocardiogram QT interval prolonged, and skin papilloma.
How much does Zelboraf® tablet cost in India?
Prices of Zelboraf may fluctuate over time due to market dynamics and regulatory changes. To get the most up-to-date details on Zelboraf 240 mg cost in India, please Call/WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
In which countries is Zelboraf approved for use?
Zelboraf is approved for use in the United States (US), European Union (EU), Switzerland, and many other countries worldwide. It was co-developed through a collaboration between Roche and Plexxikon (now part of the Daiichi Sankyo Group) under a 2006 licensing agreement.
Can Zelboraf® be available in SAARC countries?
Apart from Gulf countries, Zelboraf® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). S S Healthcare can help facilitate the legal supply of Zelboraf® tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.
Is it safe to buy Zelboraf® 240 mg Tablets online in India?
Yes, one can buy Zelboraf online in India at the lowest price from the S S Healthcare if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Zelboraf® oral tablets through legal channels.
What are the storage conditions of Zelboraf® tablets?
Store it at room temperature 20–25°C (68–77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Store it in the original container with the lid tightly closed.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
